Coronary thrombolysis with intracoronary streptokinase.
Because there are several means by which a clinician may pharmacologically activate the fibrinolytic system for thrombolysis, the clinician must understand the clinical ramifications of the use of each pharmacologic agent. Intracoronary streptokinase is one such agent whose therapeutic use, although effective in many cases, must not be taken lightly. This article, therefore, reviews the pharmacology, therapeutic uses, and possible complications that could arise as a result of intracoronary streptokinase.
D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010477:Perfusion; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013300:Streptokinase